FTC sues big pharmacy advantage professionals above insulin costs The agency introduced motion in opposition to Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list cost of daily life-conserving insulin medicine. You should not miss out on tomorrow's healthcare business news Enable https://busch-light-peach-nutriti40628.onesmablog.com/everything-about-healthcare-news-71037330